Page 508 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

486 PART IV Specific Malignancies in the Small Animal Patient

401. Barr F: Percutaneous biopsy of abdominal organs under ultrasound 423. Weisse C, Clifford CA, Holt D, et al.: Percutaneous arterial embo-
guidance, J Small Anim Pract 36:105–113, 1995. lization and chemoembolization for treatment of benign and
402. Grienie ER, David FH, Ober CP, et al.: Evaluation of canine malignant tumors in three dogs and a goat, J Am Vet Med Assoc
VetBooks.ir hepatic masses by use of triphasic computed tomography and 424. Cave TA, Johnson V, Beths T, et al.: Treatment of unresectable
221:1430–1436, 2002.
B-mode, color flow, power, and pulsed-wave Doppler ultrasonog-
raphy and correlation with histopathologic classification, Am J Vet
Res 78:1273–1283, 2017. hepatocellular adenoma in dogs with transarterial iodized oil and
chemotherapy with and without an embolic agent: a report of two
403. Warren-Smith CMR, Andrew S, Mantis P, et al.: Lack of associa- cases, Vet Comp Oncol 1:191–199, 2003.
tions between ultrasonographic appearance of parenchymal lesions 425. Iwai S, Okano S, Chikazawa S, et al.: Transcatheter arterial embo-
of the liver and histological diagnosis, J Small Anim Pract 53:168– lization for treatment of hepatocellular carcinoma in a cat, Vet Med
173, 2012. Assoc 247:1299–1302, 2015.
404. O’Brien RT, Iani M, Matheson J, et al.: Contrast harmonic ultra- 426. Yang T, Case BJ, Boston S, et al.: Microwave ablation for treat-
sound of spontaneous liver nodules in 32 dogs, Vet Radiol Ultra- ment of hepatic neoplasia in five dogs, J Am Vet Med Assoc 250:
sound 45:547–553, 2004. 79–85, 2017.
405. Kutara K, Asano K, Kito A, et al.: Contrast harmonic imaging of 427. Mori T, Ito Y, Kawabe M, et al.: Three-dimensional conformal
canine hepatic tumors, J Vet Med Sci 68:433–438, 2006. radiation therapy for inoperable massive hepatocellular carcinoma
406. Nakamura K, Takagi S, Sasaki N, et al.: Contrast-enhanced ultra- in six dogs, J Small Anim Pract 56:441–445, 2015.
sonography for characterization of canine focal liver lesions, Vet 428. Elpiner A, Brodsky E, Hazzah T, et al.: Single-agent gemcitabine
Radiol Ultrasound 51:79–85, 2010. chemotherapy in dogs with hepatocellular carcinoma, Vet Comp
407. Kanemoto H, Ohno K, Nakashima K, et al.: Characterization of Oncol 9:260–268, 2011.
canine focal liver lesions with contrast-enhanced ultrasound using 429. Fry PD, Rest JR: Partial hepatectomy in two dogs, J Small Anim
a novel contrast agent – sonazoid, Vet Radiol Ultrasound 50:188– Pract 34:192–195, 1993.
194, 2009. 430. Ogilvie GK, Powers BE, Mallinckrodt CH, et al.: Surgery and
408. Roth L: Comparison of liver cytology and biopsy diagnoses in dogs doxorubicin in dogs with hemangiosarcoma, J Vet Intern Med
and cats: 56 cases, Vet Clin Pathol 30:35–38, 2001. 10:379–384, 1996.
409. Masserdotti C, Drigo M: Retrospective study of cytologic features 431. Rassnick KM, Frimberger AE, Wood CA, et al.: Evaluation of ifos-
of well-differentiated hepatocellular carcinoma in dogs, Vet Clin famide for treatment of various canine neoplasms, J Vet Intern Med
Pathol 41:382–390, 2012. 14:271–276, 2000.
410. D’Angelica M, Fong Y, Weber S, et al.: The role of staging laparos- 432. Chung C, Bautista N, O’Connell TX: Prognosis and treatment of
copy in hepatobiliary malignancy: prospective analysis of 401 cases, bile duct carcinoma, Am Surg 64:921–925, 1998.
Ann Surg Oncol 10:183–189, 2003. 433. Cotchin E: Some tumours of dogs and cats of comparative veteri-
411. Fukushima K, Kanemoto H, Ohno K, et al.: CT characteristics nary and human interest, Vet Rec 71:1040–1050, 1959.
of primary hepatic mass lesions in dogs, Vet Radiol Ultrasound 434. Patnaik AK, Liu SK, Johnson GF: Feline intestinal adenocar-
53:252–257, 2012. cinoma. A clinicopathologic study of 22 cases, Vet Pathol 13:
412. Kutara K, Seki M, Ishikawa C, et al.: Triple-phase helical computed 1–10, 1976.
tomography in dogs with hepatic masses, Vet Radiol Ultrasound 435. Engle G, Brodey R: A retrospective study of 395 feline neoplasms,
55:7–15, 2014. J Am Anim Hosp Assoc 5:21–31, 1969.
413. Jones ID, Lamb CR, Drees R, et al.: Associations between dual- 436. Dobson JM, Samuel S, Milstein H, et al.: Canine neoplasia in the
phase computed tomography features and histopathologic diagno- UK: estimates of incidence rates from a population of insured dogs,
ses in 52 dogs with hepatic or splenic masses, Vet Radiol Ultrasound J Small Anim Pract 43:240–246, 2002.
57:144–153, 2016. 437. Demetriou JL, Brearley MJ, Constantino-Casas F, et al.:
414. Constant C, Hecht S, Craig LE, et al.: Gadoxetate disodium Intentional marginal excision of canine limb soft tissue sar-
(Gd-EOB-DTPA) contrast enhanced magnetic resonance imag- comas followed by radiotherapy, J Small Anim Pract 53:
ing characteristics of hepatocellular carcinoma in dogs, Vet Radiol 174–181, 2012.
Ultrasound 57:594–600, 2016. 438. Rissetto K, Villamil JA, Selting KA, et al.: Recent trends in feline
415. Cuccovillo A, Lamb CR: Cellular features of sonographic target intestinal neoplasia: an epidemiologic study of 1,129 cases in the
lesions of the liver and spleen in 21 dogs and a cat, Vet Radiol Ultra- veterinary medical database from 1964 to 2004, J Am Anim Hosp
sound 43:275–278, 2002. Assoc 47:28–36, 2011.
416. Stowater JL, Lamb CR, Schelling SH: Ultrasonographic features of 439. Dorn CR, Taylor DO, Schneider R, et al.: Survey of animal neo-
canine hepatic nodular hyperplasia, Vet Radiol 31:268–272, 1990. plasms in Alameda and Contra Costa Counties, California. II.
417. Martin RA, Lanz OI, Tobias KM: Liver and biliary system. In Slat- Cancer morbidity in dogs and cats from alameda county, J Natl
ter DH, editor: Textbook of small animal surgery, ed 3, Philadelphia, Cancer Inst 40:307–318, 1968.
2003, WB Saunders, pp 716–717. 440. Tamas MJ, Karlgren S, Bill RM, et al.: A short regulatory domain
418. Covey JL, Degner DA, Jackson AH, et al.: Hilar liver resection in restricts glycerol transport through yeast Fps1p, J Bio Chem
dogs, Vet Surg 38:104–111, 2009. 278:6337–6345, 2003.
419. Matsuyama A, Takagi S, Hosoya K, et al.: Impact of surgical mar- 441. Crawshaw J, Berg J, Sardinas JC, et al.: Prognosis for dogs with
gins on survival of 37 dogs with massive hepatocellular carcinoma, nonlymphomatous, small intestinal tumors treated by surgical exci-
NZ Vet J 65:277–231, 2017. sion, J Am Anim Hosp Assoc 34:451–456, 1998.
420. Iida G, Asano K, Seki M, et al.: Intraoperative identification of 442. Alroy J, Leav I, DeLellis RA, et al.: Distinctive intestinal mast cell
canine hepatocellular carcinoma with indocyanine green fluores- neoplasms of domestic cats, Lab Invest 33:159–167, 1975.
cent imaging, J Small Anim Pract 54:594–600, 2013. 443. Gabor LJ, Malik R, Canfield PJ: Clinical and anatomical features of
421. Seki M, Asano K, Ishigaki K, et al.: En block resection of a large lymphosarcoma in 118 cats, Aust Vet J 76:725–732, 1998.
hepatocellular carcinoma involving the caudal vena cava in a dog, 444. Kosovsky JE, Matthiesen DT, Patnaik AK: Small intestinal ade-
J Vet Med Sci 73:693–696, 2011. nocarcinoma in cats: 32 cases (1978-1985), J Am Vet Med Assoc
422. Hanson KR, Pigott AM, Linklater AKJ: Incidence of blood trans- 192:233–235, 1988.
fusion requirement and factors associated with transfusion follow- 445. Mahony OM, Moore AS, Cotter SM, et al.: Alimentary lym-
ing liver lobectomy in dogs and cats: 72 cases (2007–2015), J Am phoma in cats: 28 cases (1988-1993), J Am Vet Med Assoc 207:
Vet Med Assoc 251:929–934, 2017. 1593–1598, 1995.